Cite
Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease.
MLA
Xiong, Wei, et al. “Presynaptic Glycine Receptors as a Potential Therapeutic Target for Hyperekplexia Disease.” Nature Neuroscience, vol. 17, no. 2, Feb. 2014, pp. 232–39. EBSCOhost, https://doi.org/10.1038/nn.3615.
APA
Xiong, W., Chen, S.-R., He, L., Cheng, K., Zhao, Y.-L., Chen, H., Li, D.-P., Homanics, G. E., Peever, J., Rice, K. C., Wu, L., Pan, H.-L., & Zhang, L. (2014). Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease. Nature Neuroscience, 17(2), 232–239. https://doi.org/10.1038/nn.3615
Chicago
Xiong, Wei, Shao-Rui Chen, Liming He, Kejun Cheng, Yi-Lin Zhao, Hong Chen, De-Pei Li, et al. 2014. “Presynaptic Glycine Receptors as a Potential Therapeutic Target for Hyperekplexia Disease.” Nature Neuroscience 17 (2): 232–39. doi:10.1038/nn.3615.